Using antibiotics wisely
- PMID: 37732791
- DOI: 10.1097/QCO.0000000000000973
Using antibiotics wisely
Abstract
Purpose of review: This review will describe role of shorter antibiotic therapies, early switch from intravenous to oral therapy, and artificial intelligence in infectious diseases.
Recent findings: There is evidence that shorter courses of antibiotics are noninferior to standard durations of therapy. This has been demonstrated with Enterobacterales bacteremia that can be treated with 7 days of therapy, community acquired pneumonia with 3 days and ventilator associated pneumonia with just 7 days of antibiotic therapy. The conversion from intravenous to oral therapy in treating bacteremia, endocarditis and bone and joint infections is safe and effective and reduces line complications and costs. Also, for clean surgical procedures only one dose of antibiotic is needed, but it should be the most effective antibiotic which is cefazolin. This means avoiding clindamycin, removing penicillin allergies where possible for improved outcomes. Finally, the role of artificial intelligence to incorporate into using antibiotics wisely is rapidly emerging but is still in early stages.
Summary: In using antibiotics wisely, targeting such as durations of therapy and conversion from intravenous antibiotic therapy to oral are low hanging fruit. The future of artificial intelligence could automate a lot of this work and is exciting but needs to be proven.
Video abstract: http://links.lww.com/COID/A50.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Staphylococcus lugdunensis bacteremia and endocarditis treated with cefazolin and rifampin.Am J Health Syst Pharm. 2015 Jul 1;72(13):1114-8. doi: 10.2146/ajhp140498. Am J Health Syst Pharm. 2015. PMID: 26092962
-
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103. JAMA. 2020. PMID: 32044943 Free PMC article. Clinical Trial.
-
β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.Pharmacotherapy. 2017 Mar;37(3):346-360. doi: 10.1002/phar.1892. Epub 2017 Feb 7. Pharmacotherapy. 2017. PMID: 28035690 Review.
-
Comparison of immediate hypersensitivity reactions to preoperative antibiotics in patients labeled as penicillin allergic.Surgery. 2021 Sep;170(3):777-782. doi: 10.1016/j.surg.2021.02.063. Epub 2021 Apr 8. Surgery. 2021. PMID: 33838879
-
Short-course antibiotics for common infections: what do we know and where do we go from here?Clin Microbiol Infect. 2023 Feb;29(2):150-159. doi: 10.1016/j.cmi.2022.08.024. Epub 2022 Sep 6. Clin Microbiol Infect. 2023. PMID: 36075498 Review.
References
-
- Jung N, Tometten L, Draenert R. Choosing Wisely internationally - helpful recommendations for antimicrobial stewardship!. Infection 2023; 51:567–581.
-
- Rolf von den Baumen T, Crosby M, Tadrous M, et al. Measuring the impacts of the Using Antibiotics Wisely campaign on Canadian community utilization of oral antibiotics for respiratory tract infections: a time-series analysis from 2015 to. J Antimicrob Chemother 2021; 76:2472–2478.
-
- Rice LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. Clin Infect Dis 2008; 46:491–496.
-
- Spellberg B, Rice LB. The shorter is better movement: past, present, future. Clin Microbiol Infect 2023; 29:141–142.
-
- Imlay H, Laundy NC, Forrest GN, Slavin MA. Shorter antibiotic courses in the immunocompromised: the impossible dream? Clin Microbiol Infect 2023; 29:143–149.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials